Li Ping Hong
Direttore/Membro del Consiglio presso HONZ PHARMACEUTICAL CO., LTD.
Profilo
Li Ping Hong is currently the Vice Chairman & Vice President at Honz Pharmaceutical Co., Ltd., the Director at Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd., the Director at Hainan Honz Pharmaceutical Sales Co. Ltd., the General Manager & Executive Director at Guangdong Kangzhi Hospital Management Co., Ltd., and a Member-Supervisory Board at Guangdong Yuanning Pharmaceutical Co. Ltd.
Ms. Hong obtained an undergraduate degree from Guangdong Pharmaceutical University in 1993.
Posizioni attive di Li Ping Hong
| Società | Posizione | Inizio |
|---|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 20/12/2007 |
| Hainan Honz Pharmaceutical Sales Co. Ltd. | Direttore/Membro del Consiglio | - |
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | Direttore/Membro del Consiglio | - |
Guangdong Yuanning Pharmaceutical Co. Ltd.
 Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Direttore/Membro del Consiglio | - |
Guangdong Kangzhi Hospital Management Co., Ltd.
 Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Amministratore Delegato | 20/06/2018 |
Formazione di Li Ping Hong
| Guangdong Pharmaceutical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 4 |
|---|---|
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | |
| Hainan Honz Pharmaceutical Sales Co. Ltd. | |
Guangdong Yuanning Pharmaceutical Co. Ltd.
Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Health Technology |
Guangdong Kangzhi Hospital Management Co., Ltd.
Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Technology Services |
- Borsa valori
- Insiders
- Li Ping Hong
